Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
02/05/2002 | US6344546 A receptor protein with a cytoplasmic domain having protein kinase activity, a kinase insert, a transmembrane domain and an extracellular domain having three immunoglobulin-like repeats; for drug screening |
02/05/2002 | US6344544 Semaphorin-specific antibodies |
02/05/2002 | US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome |
02/05/2002 | US6344541 DKR polypeptides |
02/05/2002 | US6344446 Gene delivery |
02/05/2002 | US6344445 Herpes virus vectors and their uses |
02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
02/05/2002 | US6344440 Antisecretory factor peptides regulating pathological permeability changes |
02/05/2002 | US6344357 A efficient transfection method and kit by contacting the cells with recognition agents that bind sites on the cell surface, then separating the agent from the cells and forming holes in the surface for which substances are introduced |
02/05/2002 | US6344356 Methods for recombining nucleic acids |
02/05/2002 | US6344353 An isolated nucleic acid molecule encoding a protein; diagnosis and therapy for osteoarthritis, rheumatoid arthritis, tumor metastasis, periodontal diseases, corneal ulceration and atherosclerosis |
02/05/2002 | US6344352 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
02/05/2002 | US6344345 A method producing dna comprising a homopolymer at one or both ends and is treated with a restriction enzyme to cleave the dna at a separate non-recognition site thereby partially or fully eliminating at least one of the homopolymers |
02/05/2002 | US6344343 Product and process for membrane and soluble polypeptide segregation |
02/05/2002 | US6344342 An isolated polynucleotide encoding a polypeptide; diagnosis and therapy for infections caused by hiv-1 or hiv-2, cancers, diabetes, asthma, parkinson's disease, ulcers, allergies, congestive heart failure, kidney diseases, sexual disorders |
02/05/2002 | US6344341 Increased production of secreted proteins by recombinant yeast cells |
02/05/2002 | US6344339 Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR) |
02/05/2002 | US6344328 Method for screening for enzyme activity |
02/05/2002 | US6344327 A recombinant dna containing a reporter sequence, thermophile promoter, a marker and a targeting sequence for intergrating dna into the genome of a thermophile; for food processing, industrial waste compounds, and pharmaceutical synthesis |
02/05/2002 | US6344323 Preventing cyclooxygenase-2 expression using antisense oligonucleotides that bind polynucleotides encoding cyclooxygenase; therapy for arthritis, ulcers, inflammatory bowel disease, multiple sclerosis, and alzheimer's disease |
02/05/2002 | US6344322 Subtle mitochondrial mutations as tumor markers |
02/05/2002 | US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
02/05/2002 | US6344319 Determining copy numbers of genomic dna that has been aligned on a surface using molecular combing techniques, reacting the aligned dna with specific probes for controled genomic sequences and detect hybridization and calculate copy numbers |
02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
02/05/2002 | US6344317 Contacting a biological sample from a patient with a nucleic acid which specifically hybridizes to a target human nucleic acid sequence and detecting the presence of the target sequence; diagnosis of chronic illness such as cancer |
02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
02/05/2002 | US6344202 Nucleotide sequence encodes major outer membrane proteins, generates antibodies that react with promoter sequence for expression in the host; drugs, vaccines |
02/05/2002 | US6344201 Inhibitors of e. coli and shigella enterotoxins; used for drugs and dna vaccines |
02/05/2002 | US6344195 Administering reovirus to a ras-mediated neoplasm |
02/05/2002 | US6344194 Dissolving a virus in an aqueous solution containing 6-12 g/l of a monovalent cation salt (such as nacl or kcl), or 50-100 g/l of a hexose and atomizing |
02/05/2002 | US6344193 Insect control method with genetically engineered biopesticides |
02/05/2002 | CA2266316C Binary methods of increasing accumulation of essential amino acids in seeds |
02/05/2002 | CA2231475C Universal spacer/energy transfer dyes |
02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
02/05/2002 | CA2214495C Hydrated zirconium silicate composition for purification of nucleic acids |
02/05/2002 | CA2150714C Syndecan stimulation of cellular differentiation |
02/05/2002 | CA2089094C Expression of recombinant polypeptides with improved purification |
02/05/2002 | CA2052396C Synthetic gene coding for human parathyroid hormone |
02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
02/05/2002 | CA2016521C Fibronectin binding protein as well as its preparation |
02/05/2002 | CA2006473C Improved anti-infective therapy |
02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
02/03/2002 | CA2340783A1 Ampk-related serine/threonine kinase, designated snark |
02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
01/31/2002 | WO2002009295A2 Plant acyl-coa synthetases |
01/31/2002 | WO2002009125A1 Spherical, magnetic sio2 particles with an adjustable particle and pore size and an adjustable magnetic content, method for producing them and use of sio2 particles of this type |
01/31/2002 | WO2002008949A2 Methods and systems for evaluating a matching between measured data and standards |
01/31/2002 | WO2002008866A2 Spread spectrum meter reading system utilizing low-speed/high-power frequency hopping |
01/31/2002 | WO2002008764A1 Detection of abnormalities leading to cervical malignancy |
01/31/2002 | WO2002008469A2 Methods, systems, and articles of manufacture for evaluating biological data |
01/31/2002 | WO2002008464A1 Method for isolating and characterizing nucleic acid sequences |
01/31/2002 | WO2002008461A2 A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS |
01/31/2002 | WO2002008448A2 Non-viral linear dna vectors and methods for using the same |
01/31/2002 | WO2002008443A1 General means of labeling protein by using wheat embryo cell-free protein synthesis system |
01/31/2002 | WO2002008442A2 Means and methods for raising antibody concentration in compartments of the body of a non human animal |
01/31/2002 | WO2002008440A2 Fermentation process for epothilones |
01/31/2002 | WO2002008437A2 Process for the fermentative preparation of l-glutamic acid using coryneform bacteria |
01/31/2002 | WO2002008436A2 Mini-adenoviral vector system for vaccination |
01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
01/31/2002 | WO2002008434A2 Bicistronic influenza comprising two genes in tandem |
01/31/2002 | WO2002008433A2 Acyl coenzyme a thioesterases |
01/31/2002 | WO2002008432A2 Composition and method for increased meiotic recombination in plants |
01/31/2002 | WO2002008431A1 Compositions and methods for use thereof in modifying the genomes of microorganisms |
01/31/2002 | WO2002008430A1 A METHOD FOR PREPARING MASSIVELY RmlC PROTEIN AND PURIFIED RMLY PROTEIN OF MYCOBACTERIUM TUBERCULOSIS BY IT |
01/31/2002 | WO2002008428A2 Production of polyhydroxyalkanoates from polyols |
01/31/2002 | WO2002008426A2 Fh-binding protein of streptococcus pneumoniae |
01/31/2002 | WO2002008425A2 Haplotypes of the adrb3 gene |
01/31/2002 | WO2002008424A1 Human and rat abca2 genes |
01/31/2002 | WO2002008423A2 Adhesion molecules |
01/31/2002 | WO2002008422A1 A novel polypeptide, a human myotube protein 10.56 and the polynucleotide encoding the polypeptide |
01/31/2002 | WO2002008421A1 A novel polypeptide, a human tumor necrosis factor receptor 21.45 and the polynucleotide encoding the polypeptide |
01/31/2002 | WO2002008420A2 A method of down-regulating gene expression |
01/31/2002 | WO2002008419A1 Molecular markers |
01/31/2002 | WO2002008418A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
01/31/2002 | WO2002008412A2 Use of cyp52a2a promoter to increase gene expression in yeast |
01/31/2002 | WO2002008411A2 Methods of creating dwarf phenotypes in plants |
01/31/2002 | WO2002008410A2 Nucleic acids compositions conferring dwarfing phenotype |
01/31/2002 | WO2002008409A2 Methods for the replacement, translocation and stacking of dna in eukaryotic genomes |
01/31/2002 | WO2002008408A2 Modular vector systems |
01/31/2002 | WO2002008407A2 Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
01/31/2002 | WO2002008405A1 Isocitrate dehydrogenases, their genes, and use in antioxidative system suppressive of ros-mediated diseases |
01/31/2002 | WO2002008404A2 Production of lysosomal enzymes in plants by transient expression |
01/31/2002 | WO2002008403A2 Nucleic acid sequences encoding beta-ketoacyl-acp synthase and uses thereof |
01/31/2002 | WO2002008402A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
01/31/2002 | WO2002008401A2 Elongase genes and uses thereof |
01/31/2002 | WO2002008400A2 25233, a human aminotransferase and uses therefor |
01/31/2002 | WO2002008399A2 Human kinases |
01/31/2002 | WO2002008397A2 A human atpase and uses therefor |
01/31/2002 | WO2002008396A2 Human proteases |
01/31/2002 | WO2002008395A2 Putative human methyltransferase family member and uses thereof |
01/31/2002 | WO2002008394A2 23430, a novel human ubiquitin hydrolase family member and uses therefor |
01/31/2002 | WO2002008393A2 Serine protease from yersinia enterocolitica |
01/31/2002 | WO2002008392A2 Regulation of human matriptase-like serine protease |
01/31/2002 | WO2002008391A2 Glycerol-3-phosphate/dihydroxyacetone phosphate dual substrate acyltransferases |
01/31/2002 | WO2002008382A2 Controlled environment agriculture bioreactor for heterologous protein production |
01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
01/31/2002 | WO2002008293A2 Multivalent target binding protein |
01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |